Specific aptamer-conjugated mesoporous silica-carbon nanoparticles for HER2-targeted chemo-photothermal combined therapy

Acta Biomaterialia

Volumn 16, Issue 1, 2015, Pages 196-205

  Wang, Kaiyuan ^b   Yao, Hui ^a   Meng, Ying ^b   Wang, Yi ^a   Yan, Xueying ^b   Huang, Rongqin ^a  

^a FUDAN UNIVERSITY   (China)

^b HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Breast cancer; Chemo photothermal therapy; HB5 aptamer; HER2 positive; Mesoporous silica carbon nanoparticles

Indexed keywords

CARBON; CELLS; CYTOLOGY; DISEASES; MESOPOROUS MATERIALS; SILICA NANOPARTICLES; TUMORS;

APTAMERS; BREAST CANCER; CARBON NANOPARTICLES; CHEMO-PHOTOTHERMAL THERAPY; EPITHELIAL GROWTH; GROWTH FACTOR RECEPTORS; HB5 APTAMER; HUMAN EPITHELIAL GROWTH FACTOR RECEPTOR 2-POSITIVE; MESOPOROUS SILICAS; MESOPOROUS SILICUM-CARBON NANOPARTICLE; PHOTOTHERMAL THERAPY;

CHEMOTHERAPY;

APTAMER; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; SILICA NANOPARTICLE; CARBON; FLUORESCEIN ISOTHIOCYANATE; NANOPARTICLE; SILICON DIOXIDE;

ABSORPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCOMPATIBILITY; BREAST CANCER CELL LINE; CELL DEATH; CELL KILLING; CELL VIABILITY; CHEMOPHOTOTHERMAL COMBINED THERAPY; COMPARATIVE STUDY; COMPETITIVE INHIBITION; CONFOCAL MICROSCOPY; CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; ENERGY TRANSFER; EPITHELIUM CELL; FEMALE; FLUORESCENCE; FLUORESCENCE MICROSCOPY; HEATING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; IRRADIATION; MICROSCOPE IMAGE; NONHUMAN; PH; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; STATIC ELECTRICITY; SURFACE CHARGE; SURFACE PROPERTY; SYNTHESIS; TUMOR MICROENVIRONMENT; ZETA POTENTIAL; ANIMAL; BAGG ALBINO MOUSE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HYPERTHERMIC THERAPY; IC50; METABOLISM; MULTIMODALITY CANCER THERAPY; NUDE MOUSE; POROSITY; TEMPERATURE; TUMOR CELL LINE; ULTRASTRUCTURE;

ANIMALS; APTAMERS, NUCLEOTIDE; CARBON; CELL LINE, TUMOR; CELL SURVIVAL; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; HYPERTHERMIA, INDUCED; INHIBITORY CONCENTRATION 50; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; PHOTOCHEMOTHERAPY; POROSITY; RECEPTOR, ERBB-2; SILICON DIOXIDE; STATIC ELECTRICITY; TEMPERATURE;

EID: 84930948274     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2015.01.002     Document Type: Article

References (30)

1. Pan L, He QJ, Liu JN, Chen Y, Ma M, Zhang LL, et al. Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. J Am Chem Soc 2012;134:5722-5.
2. Wang S, Zeng D, Niu J, Wang HJ, Wang LL, Li Q, et al. Development of an efficient transdermal drug delivery system with TAT-conjugated cationic polymeric lipid vesicles. J Mater Chem B 2014;2:877-84.
3. Lu H, Wang DL, Kazane S, Javahishvili T, Tian F, Song F, et al. Site-specific antibody-polymer conjugates for siRNA delivery. J Am Chem Soc 2013;135:13885-91.
4. Chari RVJ, Miller ML, Widdison WC. Antibody-drug conjugates: an emerging concept in cancer therapy. Angew Chem Int Ed 2014;53:3796-827.
5. Gopinath SCB, Kumar PKR. Aptamers that bind to the hemagglutinin of the recent pandemic influenza virus H1N1 and efficiently inhibit agglutination. Acta Biomater 2013;9:8932-41.
6. Gao HL, Yang Z, Zhang S, Pang ZQ, Liu QF, Jiang XG. Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assays. Acta Biomater 2014;10:858-67.
7. Gao HL, Qian J, Gao SJ, Yang Z, Pang ZQ, Pan SQ, et al. Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles. Biomaterials 2012;33:5115-23.
8. Shieh Y, Yang S, Wei MF, Shieh MJ. Aptamer-based tumor-targeted drug delivery for photodynamic therapy. ACS Nano 2010;4:1433-42.
9. Dam D, Lee J, Sisco P, Co D, Zhang M, Wasielewski M, et al. Direct observation of nanoparticle cancer cell nucleus interactions. ACS Nano 2012;6:3318-26.
10. Yang XJ, Liu X, Liu Z, Pu F, Ren JS, Qu XG. Near-infrared light-triggered, targeted drug delivery to cancer cells by aptamer gated nanovehicles. Adv Mater 2012;24:2890-5.
11. Fang C, Zhao Y, Guo BY. MiR-199b-5p targets HER2 in breast cancer cells. J Cell Biochem 2013;114:1457-63.
12. Zhang J, Yuan ZF, Wang Y, Chen WH, Luo GF, Cheng SX, et al. Multifunctional envelope-type mesoporous silica nanoparticles for tumor-triggered targeting drug delivery. J Am Chem Soc 2013;135:5068-73.
13. Guo JW, Gao XL, Su L, Xia HM, Gu GZ, Pang ZQ, et al. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials 2011;32:8010-20.
14. Dong K, Liu Z, Li ZH, Ren JS, Qu XG. Hydrophobic anticancer drug delivery by a 980 nm laser-driven photothermal vehicle for efficient synergistic therapy of cancer cells in vivo. Adv Mater 2013;25:4452-8.
15. Zhang ZJ, Wang J, Chen CY. Near-infrared light-mediated nanoplatforms for cancer thermo-chemotherapy and optical imaging. Adv Mater 2013;25:3869-80.
16. Xu C, Yang DR, Mei L, Li QH, Zhu HZ, Wang TH. Targeting chemophotothermal therapy of hepatoma by gold nanorods/graphene oxide core/shell nanocomposites. ACS Appl Mater Interfaces 2013;5:12911-20.
17. Wang Y, Wang KY, Yan XY, Huang RQ. A general strategy for dual-triggered combined tumor therapy based on template semi-graphitized mesoporous silica nanoparticles. Adv Healthcare Mater 2014;3:485-9.
18. Liu Z, Duan JH, Song YM, Ma J, Wang FD, Lu X, et al. Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells in vitro. J Transl Med 2012;10:148-57.
19. Zelenak V, Badanicova M, Halamova D, Cejka J, Zukal A, Murafa N, et al. Aminemodified ordered mesoporous silica: effect of pore size on carbon dioxide capture. Chem Eng J 2008;144:336-42.
20. Wang J, Dong B, Chen B, Jiang ZL, Song HW. Selective photothermal therapy for breast cancer with targeting peptide modified gold nanorods. Dalton Trans 2012;41:11134-44.
21. Liu SH, Guo YB, Huang RQ, Li JF, Huang SX, Kuang YY, et al. Gene and doxorubicin co-delivery system for targeting therapy of glioma. Biomaterials 2012;33:4907-16.
22. Ma M, Chen HR, Chen Y, Zhang K, Wang X, Cui XZ, et al. Hyaluronic acid-conjugated mesoporous silica nanoparticles: excellent colloidal dispersity in physiological fluids and targeting efficacy. J Mater Chem 2012;22:5615-21.
23. Wang Y, Shi W, Song WS, Wang L, Liu XG, Chen J, et al. Tumor cell targeted delivery by specific peptide-modified mesoporous silica nanoparticles. J Mater Chem 2012;22:14608-16.
24. Wang Y, Wang KY, Zhao JF, Liu XG, Bu J, Yan XY, et al. Multifunctional mesoporous silica-coated graphene nanosheet used for chemophotothermal synergistic targeted therapy of glioma. J Am Chem Soc 2013;135:4799-804.
25. Shen S, Tang HY, Zhang XT, Ren JF, Pang ZQ, Wang DG, et al. Targeting mesoporous silica-encapsulated gold nanorods for chemo-photothermal therapy with near-infrared radiation. Biomaterials 2013;34:3150-8.
26. Zhang ZJ, Wang LM, Wang J, Jiang XM, Li XH, Hu ZJ, et al. Mesoporous silicacoated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment. Adv Mater 2012;24:1418-23.
27. Wang C, Xu H, Liang C, Liu YM, Li ZW, Yang GB, et al. Iron oxide@polypyrrole nanoparticles as a multifunctional drug carrier for remotely controlled cancer therapy with synergistic antitumor effect. ACS Nano 2013;7:6782-95.
28. Fang WJ, Tang SH, Liu PX, Fang XL, Gong JW, Zheng NF. Pd nanosheet-covered hollow mesoporous silica nanoparticles as a platform for the chemophotothermal treatment of cancer cells. Small 2012;8:3816-22.
29. Tian B, Wang C, Zhang S, Feng LZ, Liu Z. Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. ACS Nano 2011;5:7000-9.
30. Feng LZ, Yang XZ, Shi XZ, Tan XF, Peng R, Wang J, et al. Polyethylene glycol and polyethylenimine dual-functionalized nano-graphene oxide for photothermally enhanced gene delivery. Small 2013;9:1989-97.